Silver Member: Abbott

Every day and around the world, Abbott is discovering new ways to make life better – creating more possibilities for more people through the power of health.

Silver Member: Astellas

At Astellas, we build on our proud specialty heritage to develop innovative products that improve the lives of patients. To achieve this goal, our strategy is to focus on select therapeutic areas in order to develop a deep understanding of specific health conditions and the unique needs of our patients and customers.

In the United States, we concentrate our efforts in the following key therapeutic areas: cardiology, immunology, infectious disease, neuroscience, oncology and urology. We also are expanding our expertise to advancements […]

Silver Member: Biogen

Biogen is one of the world’s leading biotechnology companies, with a focus on developing therapies for serious neurological, autoimmune and rare diseases. Founded in 1978, our work in biologics and small-molecule drug discovery has led to the world’s most extensive portfolio of multiple sclerosis therapies and innovative new treatments for hemophilia patients. Our experience, capabilities and passion for innovation have enabled us to build a pipeline and develop advanced research programs that include exploration of potential candidates for serious and […]

Silver Member: CSL Behring

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat rare and serious conditions that include immunodeficiency and autoimmune diseases, hereditary and acquired bleeding disorders, hereditary angioedema, hereditary emphysema, and in transplantation and critical care.

Our commitment to saving lives and improving the quality of life for people with serious and rare conditions is evident in […]

Silver Member: Gilead Sciences, Inc.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. We strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead’s portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.

Our portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single […]

Silver Member: Grace Bio-Labs

Grace Bio-Labs has been designing and developing molecular diagnostics tools, services, and consumable products for more than 30 years. Our agile, research-driven biotechnology company prides itself on responsive customer service and is globally recognized for quality in everything we do.

As a development partner, our custom manufacturing capabilities help drive research and development in university research laboratories, biotech companies, private research facilities, and pharmaceutical companies.

Silver Member: Horizon Pharma

Our goal is to build a new kind of biopharmaceutical company; one that challenges industry norms and believes that when patients benefit, everyone benefits.

Horizon Pharma plc is a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. We market 11 medicines through our rare disease, rheumatology and primary care business units.

Founded in 2008 as a small startup with only a handful of employees and no office […]

Silver Member: MacDonald-Miller

We are a full service-design build mechanical contractor in the Pacific Northwest. With over 1,000 talented professionals, 10 locations and our own prefabrication shop, no project is too big or too small. We’ve helped shape the local landscape for over half a century with buildings that operate in the most efficient manner possible. We like to think we’re saving the planet one building at a time.

Facility managers, owners and tenants can all rest assured that our experience as industry leaders lends […]